India Unit Of Sanofi-Aventis Told By WHO 5-Disease Vaccine Has Problem
This article was originally published in PharmAsia News
Executive Summary
The Indian subsidiary of French drug maker Sanofi-Aventis has been told by the United Nations it was suspending purchase and use of the Shan5 vaccine for five diseases, including tetanus